World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
22987
World Ranking
1573
National Ranking
786

Stephen Gottschalk publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen Gottschalk sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 424 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen Gottschalk D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen Gottschalk sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stephen Gottschalk is affiliated with St. Jude Children's Research Hospital in the United States. Their research spans several interconnected fields, primarily focusing on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology.

Gottschalk's work is centered on oncology, immunology, molecular biology, genetics, and hematology. These subfields reflect their engagement with cancer biology, immune system functioning, gene regulation, and blood-related diseases.

The scientist's main research topics include CAR-T cell therapy research, immune cell function and interaction, virus-based gene therapy research, immunotherapy and immune responses, hematopoietic stem cell transplantation, viral infectious diseases and gene expression in insects, and nanowire synthesis and applications.

Key recent papers authored or co-authored by Gottschalk include:

  • CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality? (2020) in Molecular Therapy
  • Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity (2021) in Science Translational Medicine
  • CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity (2021) in Blood
  • RASA2 ablation in T cells boosts antigen sensitivity and long-term function (2022) in Nature
  • Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma (2020) in Nature Communications

Gottschalk frequently publishes in the following venues:

  • Blood
  • Transplantation and Cellular Therapy
  • Neuro-Oncology
  • Cytotherapy
  • Regular and Young Investigator Award Abstracts

The scientist has collaborated regularly with co-authors including Aimee C. Talleur, Brandon M. Triplett, Swati Naik, Giedre Krenciute, and Mireya Paulina Velasquez. These collaborations indicate active engagement with peers to advance their fields of study.

Best Publications

  • Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

    Nabil Ahmed;Vita S. Brawley;Meenakshi Hegde;Catherine Robertson

  • HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

    Nabil Ahmed;Nabil Ahmed;Vita Brawley;Vita Brawley;Meenakshi Hegde;Meenakshi Hegde;Kevin Bielamowicz

  • Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

    Meenakshi Hegde;Malini Mukherjee;Malini Mukherjee;Zakaria Grada;Antonella Pignata

  • Design and development of therapies using chimeric antigen receptor-expressing T cells

    Gianpietro Dotti;Stephen Gottschalk;Barbara Savoldo;Malcolm K. Brenner

  • Post-transplant lymphoproliferative disorders.

    Stephen Gottschalk;Cliona M. Rooney;Helen E. Heslop

  • Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

    Catherine M. Bollard;Catherine M. Bollard;Stephen Gottschalk;Stephen Gottschalk;Vicky Torrano;Vicky Torrano;Oumar Diouf;Oumar Diouf

  • TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy

    Zakaria Grada;Zakaria Grada;Meenakshi Hegde;Meenakshi Hegde;Tiara Byrd;Tiara Byrd;Donald R Shaffer;Donald R Shaffer

  • Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

    Ifigeneia Tzannou;Anastasia Papadopoulou;Swati Naik;Kathryn Leung

  • HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors

    Nabil Ahmed;Vita S. Salsman;Yvonne Kew;Donald Shaffer

  • A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells.

    S. Gottschalk;J. T. Sparrow;J. Hauer;M. P. Mims

  • Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

    Jeffrey I. Cohen;Elaine S. Jaffe;Janet K. Dale;Stefania Pittaluga

  • Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma

    Sunitha Kakarla;Kevin K H Chow;Kevin K H Chow;Melinda Mata;Melinda Mata;Donald R Shaffer;Donald R Shaffer

  • CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

    Jessica Wagner;Elizabeth Wickman;Christopher DeRenzo;Stephen Gottschalk

  • Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

    Catherine M. Bollard;Stephen Gottschalk;Ann M. Leen;Heidi Weiss

  • An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

    Stephen Gottschalk;Catherine Y. C. Ng;Margot Perez;Colton A. Smith

  • Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

    Barbara Savoldo;John A. Goss;John A. Goss;Markus M. Hammer;Markus M. Hammer;Lan Zhang;Lan Zhang

  • Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.

    Brooke Prinzing;Caitlin C. Zebley;Christopher T. Petersen;Yiping Fan

  • Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.

    Giedre Krenciute;Giedre Krenciute;Brooke L. Prinzing;Zhongzhen Yi;Zhongzhen Yi;Meng Fen Wu

  • Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

    Thomas Shum;Thomas Shum;Bilal Omer;Bilal Omer;Haruko Tashiro;Robert L. Kruse;Robert L. Kruse

  • T cells redirected to EphA2 for the immunotherapy of glioblastoma.

    Kevin Kh Chow;Swati Naik;Sunitha Kakarla;Vita S. Brawley

  • Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

    Ulrike Gerdemann;Jacqueline M Keirnan;Usha L Katari;Ryu Yanagisawa

  • Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma.

    Whay-Kuang Chia;Marissa Teo;Who-Whong Wang;Bernett Lee

Frequent Co-Authors

Helen E. Heslop
Helen E. Heslop Baylor College of Medicine
Malcolm K. Brenner
Malcolm K. Brenner Baylor College of Medicine
Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine
Catherine M. Bollard
Catherine M. Bollard George Washington University
Gianpietro Dotti
Gianpietro Dotti University of North Carolina at Chapel Hill
Adrian P. Gee
Adrian P. Gee Baylor College of Medicine
Ann M. Leen
Ann M. Leen Baylor College of Medicine
Hao Liu
Hao Liu Indiana University
Winfried S. Wels
Winfried S. Wels Goethe University Frankfurt
Barbara Savoldo
Barbara Savoldo University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related online degrees can open diverse career opportunities. Many students pursue nursing-related programs that complement immunological knowledge, such as the best online BSN programs for non nurses, which provide a strong foundation in patient care and biological sciences.

Accelerated nursing programs are another popular option. Choosing a nurse practitioner accelerated program can fast-track your journey to advanced practice roles, which often intersect with immunology in clinical settings.

For practicing family nurse practitioners aiming to specialize further, acquiring acute care certification for FNP can enhance your ability to manage critical immunological cases and acute patient care.

Finally, understanding the job market is crucial. Transparency around DNP salary transparency helps in making informed decisions about education investments and career pathways in nursing and immunology-related fields.

Best Scientists Citing Stephen Gottschalk

Trending Scientists

Recently Published Articles